The challenge of early diagnosis in ankylosing spondylitis.

@article{Oshea2007TheCO,
  title={The challenge of early diagnosis in ankylosing spondylitis.},
  author={Finbar D O'shea and David C. Salonen and Robert D. Inman},
  journal={The Journal of rheumatology},
  year={2007},
  volume={34 1},
  pages={
          5-7
        }
}
Ankylosing spondylitis (AS) is a chronic, disabling rheumatic disease characterized by inflammatory back pain, restricted spinal mobility, and frequently peripheral arthritis, enthesitis, and acute anterior uveitis. Patients fulfill classification criteria for AS if characteristic radiological changes of the sacroiliac (SI) joint are present, together with defined clinical symptoms and physical findings1. AS belongs to a larger, more encompassing group of related diseases termed… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

  • D van der Heijde, A Kivitz, MH Schiff
  • Arthritis Rheum ;54:2136-46
  • 2006

Efficacy and safety of infliximab in patients with ankylosing spondylitis : results of a randomized , placebo - controlled trial ( ASSERT )

  • D vanderHeijde, B Dijkmans, P Geusens
  • Arthritis Rheum
  • 2005

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582-91

  • D van der Heijde, B Dijkmans, P Geusens
  • 2005

Similar Papers

Loading similar papers…